Skip to content

Identifying the Utility and Challenges of a Collaborative Genetic Medicine Model through a Questionnaire Survey

Identifying the Utility and Challenges of a Collaborative Genetic Medicine Model through a Questionnaire Survey - Identifying the Utility and Challenges of a Collaborative Genetic Medicine Model through a Questionnaire Survey

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058678
Enrollment
50
Registered
2025-10-01
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Cancer Syndrome

Interventions

None listed

Sponsors

Japanese Foundation of Cancer Research, JFCR
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthcare Professionals:1.Aged 18 years or older 2. Medical professionals who are interested in hereditary cancer care (regardless of prior experience or certification) Patients and Their Family Members:1. Aged 18 years or older 2. Individuals who seek genetic counseling in relation to hereditary cancer syndromes

Exclusion criteria

Exclusion criteria: Individuals Ineligible to Complete the Questionnaire

Design outcomes

Primary

MeasureTime frame
Changes in the level of understanding of genetic medicine identified by comparing pre- and post-intervention questionnaire responses from healthcare professionals.

Countries

Japan

Contacts

Public ContactKOTA ISHIOKA

The Cancer Institute Hospital Of JFCR Clinical Genetic Oncology

kota.ishioka@jfcr.or.jp+81-3-3520-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026